Zhao Z, Zou X, Zhu Y, He Y, Jebessa E, Zhang J
Animals (Basel). 2025; 15(4).
PMID: 40003070
PMC: 11851890.
DOI: 10.3390/ani15040590.
Guo J, Huang Z, Wang Q, Wang M, Ming Y, Chen W
J Nanobiotechnology. 2025; 23(1):4.
PMID: 39754127
PMC: 11697683.
DOI: 10.1186/s12951-024-02935-1.
Corrado A, Aceto R, Miglietta S, Silvestri R, DellAnno I, Lepori I
3 Biotech. 2024; 14(2):45.
PMID: 38261961
PMC: 10798938.
DOI: 10.1007/s13205-023-03878-4.
Rahul K, Singh S, Kumar S, Tewarson V, Hakim M, Kaushik K
Heart Views. 2024; 24(4):201-207.
PMID: 38188709
PMC: 10766161.
DOI: 10.4103/heartviews.heartviews_49_23.
Zadabbas Shahabadi H, Akbarzadeh A, Ofoghi H, Kadkhodaei S
Front Plant Sci. 2023; 14:1150436.
PMID: 37275253
PMC: 10235511.
DOI: 10.3389/fpls.2023.1150436.
A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases.
Roshanravan N, Tutunchi H, Najafipour F, Dastouri M, Ghaffari S, Jebeli A
J Cardiovasc Thorac Res. 2022; 14(2):77-83.
PMID: 35935390
PMC: 9339732.
DOI: 10.34172/jcvtr.2022.14.
Genome Editing by CRISPR-Cas: A Game Change in the Genetic Manipulation of .
Ghribi M, Nouemssi S, Meddeb-Mouelhi F, Desgagne-Penix I
Life (Basel). 2020; 10(11).
PMID: 33233548
PMC: 7699682.
DOI: 10.3390/life10110295.
Lysosomal storage diseases: current therapies and future alternatives.
Leal A, Espejo-Mojica A, Sanchez O, Ramirez C, Reyes L, Cruz J
J Mol Med (Berl). 2020; 98(7):931-946.
PMID: 32529345
DOI: 10.1007/s00109-020-01935-6.
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment.
Wu X, Ma W, Mei C, Chen X, Yao Y, Liu Y
J Exp Clin Cancer Res. 2020; 39(1):97.
PMID: 32487115
PMC: 7268395.
DOI: 10.1186/s13046-020-01603-0.
Current Approaches and Applications in Avian Genome Editing.
Lee J, Kim D, Lee K
Int J Mol Sci. 2020; 21(11).
PMID: 32486292
PMC: 7312999.
DOI: 10.3390/ijms21113937.
CRISPR-Cas9 System for Genome Engineering of Photosynthetic Microalgae.
Patel V, Soni N, Prasad V, Sapre A, Dasgupta S, Bhadra B
Mol Biotechnol. 2019; 61(8):541-561.
PMID: 31140149
DOI: 10.1007/s12033-019-00185-3.
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E, Golino G, Pisano A, Albano F, Falcone C, Ceglia S
Cell Death Dis. 2019; 10(4):320.
PMID: 30975981
PMC: 6459904.
DOI: 10.1038/s41419-019-1557-6.
Essential function of NHE8 in mouse retina demonstrated by AAV-mediated CRISPR/Cas9 knockdown.
Xia C, Ferguson I, Li M, Kim A, Onishi A, Li L
Exp Eye Res. 2018; 176:29-39.
PMID: 29958869
PMC: 9236278.
DOI: 10.1016/j.exer.2018.06.026.
CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
Baliou S, Adamaki M, Kyriakopoulos A, Spandidos D, Panayiotidis M, Christodoulou I
Int J Oncol. 2018; 53(2):443-468.
PMID: 29901119
PMC: 6017271.
DOI: 10.3892/ijo.2018.4434.
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.
Huang L, Tam K, Liu W, Lin C, Hsu K, Hsieh W
Dis Markers. 2018; 2018:3835783.
PMID: 29849821
PMC: 5925145.
DOI: 10.1155/2018/3835783.
Post genomics era for orchid research.
Tsai W, Dievart A, Hsu C, Hsiao Y, Chiou S, Huang H
Bot Stud. 2017; 58(1):61.
PMID: 29234904
PMC: 5727007.
DOI: 10.1186/s40529-017-0213-7.
Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion.
Vaschetto L
Curr Genet. 2017; 64(2):405-412.
PMID: 29032444
DOI: 10.1007/s00294-017-0765-9.
The Rise of CRISPR/Cas for Genome Editing in Stem Cells.
Shui B, Hernandez Matias L, Guo Y, Peng Y
Stem Cells Int. 2016; 2016:8140168.
PMID: 26880991
PMC: 4736575.
DOI: 10.1155/2016/8140168.
Genome-editing technologies and their potential application in horticultural crop breeding.
Xiong J, Ding J, Li Y
Hortic Res. 2015; 2:15019.
PMID: 26504570
PMC: 4595993.
DOI: 10.1038/hortres.2015.19.
CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
Prykhozhij S, Rajan V, Gaston D, Berman J
PLoS One. 2015; 10(3):e0119372.
PMID: 25742428
PMC: 4351176.
DOI: 10.1371/journal.pone.0119372.